Exploring 5-MeO-MIPT. To explore a different substance…

Names:
5-MeO-MIPT · Tryptamine, N-isopropyl-5-methoxy-N-methyl · Indole, 3-[2-(isopropylmethylamino)ethyl]-5-methoxy · N-Isopropyl-5-methoxy-N-methyltryptamine · 3-[2-(Isopropylmethylamino)ethyl]-5-methoxyindole
IUPAC name:
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
ID: 5040 · Formula: C15H22N2O · Molecular weight: 246.348
InChI: InChI=1S/C15H22N2O/c1-11(2)17(3)8-7-12-10-16-15-6-5-13(18-4)9-14(12)15/h5-6,9-11,16H,7-8H2,1-4H3

Brandt, SD; Tirunarayanapuram, SS; Freeman, S; Dempster, N; Barker, SA; Daley, PF; Cozzi, NV; Martins, CPB. Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines. J. Labelled Compd. Radiopharm., 1 Nov 2008, 51 (14), 423–429. 169 kB. http://dx.doi.org/10.1002/jlcr.1557

Rodriguez-Cruz, SE. Analysis and characterization of designer tryptamines using electrospray ionization mass spectrometry (ESI-MS). Microgram J., 1 Jul 2005, 3 (3–4), 107–129. 1.6 MB.

Spratley, TK; Hays, PA; Geer, LC; Cooper, SD; McKibben, TD. Analytical profiles for five “designer” tryptamines. Microgram J., 1 Jan 2005, 3 (1–2), 54–68. 473 kB.

Shulgin, AT. 5-Methoxy-N-ethyl-N-isopropyltryptamine, 5-MeO-MIPT, 5-MeO-DIPT, 5-MeO-EIPT. Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 27 Feb 2002.

Ray, TS. Psychedelics and the human receptorome. PLOS ONE, 2 Feb 2010, 5 (2), e9019. 791 kB. http://dx.doi.org/10.1371/journal.pone.0009019

Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Analysis of phenethylamines and tryptamines in designer drugs using gas chromatography-mass spectrometry. J. Health Sci., 2008, 54 (1), 89–96. 1.9 MB. http://dx.doi.org/10.1248/jhs.54.89

Brandt, SD; Freeman, S; Fleet, IA; Alder, JF. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS. Analyst, 1 Jan 2005, 130 (9), 1258–1262. 250 kB. http://dx.doi.org/10.1039/b504001a

Brandt, SD; Freeman, S; Fleet, IA; McGagh, P; Alder, JF. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR. Analyst, 2005, 130 (3), 330–344. 403 kB. http://dx.doi.org/10.1039/b413014f

Repke, DB; Grotjahn, DB; Shulgin, AT. Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents. J. Med. Chem., 1 Jan 1985, 28 (7), 892–896. 711 kB. http://dx.doi.org/10.1021/jm00145a007

Brandt, SD; Martins, CP. Analytical methods for psychoactive N,N-dialkylated tryptamines. Trends Anal. Chem., 1 Sep 2010, 29 (8), 858–869. 446 kB. http://dx.doi.org/10.1016/j.trac.2010.04.008 #28

McKenna, DJ; Repke, DB; Lo, L; Peroutka, SJ. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology, 1 Mar 1990, 29 (3), 191–198. 679 kB. http://dx.doi.org/10.1016/0028-3908(90)90001-8

Peroutka, SJ; McCarthy, BG; Guan, X. 5-Benzyloxytryptamine: a relatively selective 5-hydroxytryptamine1D/1B agent. Life Sci., 1 Jan 1991, 49 (6), 409–418. 556 kB. http://dx.doi.org/10.1016/0024-3205(91)90582-V

Blough, BE; Landavazo, A; Decker, AM; Partilla, JS; Baumann, MH; Rothman, RB. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology, 1 Oct 2014, 231 (21), 4135-4144. 298 kB. http://dx.doi.org/10.1007/s00213-014-3557-7

Melatonin
5-MeO-DET
5-MeO-DIPT
5-MeO-DMT
5-MeO-NMT
5-MeO-DPT
5-MeO-NCPT
5-MeO-T
N-Hexanoyl-5-MeO-T
N-Octanoyl-5-MeO-T
N-Heptafluorobutyroyl-5-MeO-T
5-MeO-DALT
5MT-NBOMe · 5MT-NB2OMe
5-MeO-EIPT
5-MeO-NALT
5-MeO-DPRT
5-MeO-MET
5MT-NB
5MT-NBOH
5MT-NB2OTFM
5MT-NB4OMe
5MT-NB4NO2
5MT-NB4NH2
5MT-NB4Me
5MT-NB4I
5-MeO-NBpBrT · 5MT-NB4B
5MT-NB4Cl
5MT-NB4F
5-MeO-NET
428
427
5-MeO-NIPT
5-MeO-MPT
5-MeO-EPT
5-MeO-DIBT
5-MeO-DBT
5-MeO-MIBT
5655
5657
5658
5659
5660
5661
5662
5663
5664
5665
5666
5667
5668
5669
5670
5671
5672
5673
5674
5675
5676
5677
5678
5679
5680
5681
5682
5683
5684
5685
5686
5687
5688
5689
5690
5691
5692
5694
5-MeO-MALT
5696
5697
5698
Methyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
tert-Butyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N2-methylglycinamide
5712
5713
5MT-NB3TFM
5MT-NB3Me
5MT-NB3I
5MT-NB3Cl
5MT-NB3F
5MT-NB3B
5MT-NB2B · 5MT-NBBr
5MT-NB3OMe
5MT-NB3SMe
5-MeO-2-Me-MPT
MIPT
5-EtO-MIPT
5,6-MeO-MIPT
5-MeO-pyr-T
5-MeO-mor-T
5-MeO-pip-T
5-MeO-MPMI
5-MeO-ICPA
5-MeO-N-Me-IPYR
5-MeO-DET
4-MeO-MIPT
4-HO-MBT
4-HO-MIBT
4-HO-MSBT
4-HO-MTBT
4-MeO-DET
6-MeO-MIPT
7-MeO-MIPT
EMDT
5-MeO-MPT
5-EtO-MET
5-MeO-2-Me-MET
5-MeO-1-Pr-AMT
1-Et-5-MeO-DMT
5-PeO-T
Melatonin
5-MeO-DET
5-MeO-DIPT
5-MeO-DMT
5-MeO-NMT
5-MeO-DPT
5-MeO-NCPT
5-MeO-T
N-Hexanoyl-5-MeO-T
N-Octanoyl-5-MeO-T
N-Heptafluorobutyroyl-5-MeO-T
5-MeO-DALT
5MT-NBOMe · 5MT-NB2OMe
5-MeO-EIPT
5-MeO-NALT
5-MeO-DPRT
5-MeO-MET
5MT-NB
5MT-NBOH
5MT-NB2OTFM
5MT-NB4OMe
5MT-NB4NO2
5MT-NB4NH2
5MT-NB4Me
5MT-NB4I
5-MeO-NBpBrT · 5MT-NB4B
5MT-NB4Cl
5MT-NB4F
5-MeO-NET
428
427
5-MeO-NIPT
5-MeO-MPT
5-MeO-EPT
5-MeO-DIBT
5-MeO-DBT
5-MeO-MIBT
5655
5657
5658
5659
5660
5661
5662
5663
5664
5665
5666
5667
5668
5669
5670
5671
5672
5673
5674
5675
5676
5677
5678
5679
5680
5681
5682
5683
5684
5685
5686
5687
5688
5689
5690
5691
5692
5694
5-MeO-MALT
5696
5697
5698
Methyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
tert-Butyl N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N2-methylglycinamide
5712
5713
5MT-NB3TFM
5MT-NB3Me
5MT-NB3I
5MT-NB3Cl
5MT-NB3F
5MT-NB3B
5MT-NB2B · 5MT-NBBr
5MT-NB3OMe
5MT-NB3SMe
5-MeO-2-Me-MPT
MIPT
5-EtO-MIPT
5,6-MeO-MIPT
5-MeO-pyr-T
5-MeO-mor-T
5-MeO-pip-T
5-MeO-MPMI
5-MeO-ICPA
5-MeO-N-Me-IPYR
5-MeO-DET
4-MeO-MIPT
4-HO-MBT
4-HO-MIBT
4-HO-MSBT
4-HO-MTBT
4-MeO-DET
6-MeO-MIPT
7-MeO-MIPT
EMDT
5-MeO-MPT
5-EtO-MET
5-MeO-2-Me-MET
5-MeO-1-Pr-AMT
1-Et-5-MeO-DMT
5-PeO-T
24 November 2017 · Creative Commons BY-NC-SA ·